GRAEFF JOHANNES,HAGGARTY STEPHEN J.,GUAN JI-SONG,HOLSON EDWARD,TSAI LI-HUEI,WAGNER FLORENCE
申请号：
NZ59975710
公开号：
NZ599757A
申请日:
2010.10.29
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
The disclosure relates to a use of 4-(acetylamino)-N-(2aminophenyl)benzamide (CI-994) or dinaline or a pharmaceutically acceptable salt, ester, prodrug or metabolite thereof in the manufacture of a medicament for the treatment of Alzheimer&rsquos disease, Huntington&rsquos disease, for improving cognitive function in a normal subject and for promoting fear extinction in a subject.
